Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Réda, Bouabdallah"'
Autor:
Aurore Perrot, Hélène Monjanel, Réda Bouabdallah, Philippe Quittet, Clémentine Sarkozy, Marc Bernard, Aspasia Stamatoullas, Cécile Borel, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Marion Fournier, Franck Morschhauser, Pauline Brice
Publikováno v:
Haematologica, Vol 101, Iss 4 (2016)
Brentuximab vedotin was reported to be effective and safe against refractory/relapsed Hodgkin lymphoma in cohorts of between 12 to 102 patients. Herein we report our retrospective analysis of the French experience with brentuximab vedotin used alone
Externí odkaz:
https://doaj.org/article/20f61625144a461e9bfb2fd5049b5b39
Autor:
Christophe, Fermé, José, Thomas, Pauline, Brice, Olivier, Casasnovas, Andrej, Vranovsky, Serge, Bologna, Pieternella J, Lugtenburg, Réda, Bouabdallah, Patrice, Carde, Catherine, Sebban, Houchingue, Eghbali, Gilles, Salles, Gustaaf W, van Imhoff, Antoine, Thyss, Evert M, Noordijk, Oumédaly, Reman, Marnix L M, Lybeert, Maud, Janvier, Michele, Spina, Bruno, Audhuy, John M M, Raemaekers, Richard, Delarue, Bruno, Anglaret, Okke, de Weerdt, Zora, Marjanovic, Robbert J H A, Tersteeg, Daphne, de Jong, Josette, Brière, Michel, Henry-Amar
Publikováno v:
European journal of cancer (Oxford, England : 1990). 81
For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down. The H9-U trial compared three modalities of chemotherapy followed by involved-field radiotherapy (IFRT) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f1d0049d68962e0b230d88903c6e87b
https://pubmed.ncbi.nlm.nih.gov/28601705
https://pubmed.ncbi.nlm.nih.gov/28601705
Publikováno v:
Bulletin du cancer. 103(12)
Lymphoma is one of the most frequent cancers in adolescent and young adults. Hodgkin Lymphoma is curable in more than 90% of cases. Recent pediatric and adults protocols aimed to decrease long term toxicities (mostly gonadic and cardiovascular) and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c92e1b4f4d06c17c453d009b69bd5a9d
https://pubmed.ncbi.nlm.nih.gov/27866679
https://pubmed.ncbi.nlm.nih.gov/27866679
Autor:
Aurélie, Jeanne, Myriam, Aras, François, Eisinger, Gauthier, Bellagamba, Sylvain, Garciaz, Marie-Pascale, Lehucher-Michel, Réda, Bouabdallah
Publikováno v:
Bulletin du cancer. 101(3)
This study investigated a possible link between the occupational or domestic exposure to animals and a histological subgroup of non-Hodgkin lymphomas (LNH) (diffuse large B-cell lymphomas [LDGCB], follicular lymphomas [LF], indolent non-follicular LN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef4c338e303ca007871d868f57ff473b
https://pubmed.ncbi.nlm.nih.gov/24691187
https://pubmed.ncbi.nlm.nih.gov/24691187
Autor:
Réda, BOUABDALLAH
Le raisonnement à partir de cas (RàPC) est un paradigme issu de l'intelligence artificielle qui permet la mise en place d'un système à base de connaissances. Il consiste à résoudre un nouveau problème en se remémorant et en adaptant un ou plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2678::677d62f97b88bbcb3bf88d1f250e4b2c
http://dspace.univ-tlemcen.dz/handle/112/3335
http://dspace.univ-tlemcen.dz/handle/112/3335
Autor:
François Guilhot, Claude Chastang, Mauricette Michallet, Agnès Guerci, Jean-Luc Harousseau, Frédéric Maloisel, Réda Bouabdallah, Denis Guyotat, Nathalie Cheron, Franck Nicolini, Jean-François Abgrall, Joseph Tanzer, Maurice Navarro, Dominique Bordessoule, Patrick Morice, Norbert Ifrah, Henri Rochant, Jean-Pierre Vilque, Martine Delain, Francis Bauters, Joëlle Guilhot
Publikováno v:
New England Journal of Medicine. 337:223-229
Background Treatment with interferon prolongs survival in chronic myelogenous leukemia. We conducted a clinical trial to assess the efficacy of treatment with a combination of interferon and cytarabine. Methods Previously untreated patients with chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78304572c0ca10d5a52d9b695075255d
https://doi.org/10.1056/nejm199707243370402
https://doi.org/10.1056/nejm199707243370402
Autor:
Sylvain, Garciaz, Diane, Coso, Frederic, Peyrade, Sabine, Fürst, Ségolène, Duran, Bruno, Chetaille, Isabelle, Brenot-Rossi, Raynier, Devillier, Angela, Granata, Didier, Blaise, Réda, Bouabdallah
Publikováno v:
Hematological oncology. 32(4)
Patients with relapsed or refractory Hodgkin lymphoma (RR-HL) have poor outcomes. Brentuximab vedotin (BV), an antibody-drug conjugate comprising an anti-CD30 antibody conjugated to the potent anti-microtubule agent, monomethyl auristatin E, induces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce0ec33bc29099bb677c771598db37d4
https://pubmed.ncbi.nlm.nih.gov/24301099
https://pubmed.ncbi.nlm.nih.gov/24301099
Autor:
Jean, el-Cheikh, Roberto, Crocchiolo, Sabine, Fürst, Stefania, Bramanti, Barbara, Sarina, Angela, Granata, Catherine, Faucher, Bilal, Mohty, Reda, Bouabdallah, Vey, Norbert, Chabannon, Christian, Armando, Santoro, Didier, Blaise, Luca, Castagna, Samia, Harbi, Blaise, Didier
Publikováno v:
In Blood 15 November 2013 122(21):4564-4564
Autor:
Jean, El-Cheikh *, Roberto, Crocchiolo *, Sabine, Fürst *, Stefania, Bramanti *, Barbara, Sarina *, Angela, Granata *, Catherine, Faucher *, Bilal, Mohty *, Samia, Harbi *, Reda, Bouabdallah *, Norbert, Vey *, Armando, Santoro *, Christian, Chabannon *, Luca, Castagna *, Blaise, Didier
Publikováno v:
In Blood 15 November 2013 122(21):3288-3288